Truong-Bolduc Q C, Dunman P M, Strahilevitz J, Projan S J, Hooper D C
Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114-2696, USA.
J Bacteriol. 2005 Apr;187(7):2395-405. doi: 10.1128/JB.187.7.2395-2405.2005.
In an analysis of the resistance mechanisms of an mgrA mutant, we identified two genes encoding previously undescribed transporters, NorB and Tet38. norB was 1,392 bp and encoded a predicted 49-kDa protein. When overexpressed, NorB led to an increase in resistance to hydrophilic quinolones, ethidium bromide, and cetrimide and also to sparfloxacin, moxifloxacin, and tetracycline, a resistance phenotype of the mgrA mutant. NorA and NorB shared 30% similarity, and NorB shared 30 and 41% similarities with the Bmr and Blt transporters of Bacillus subtilis, respectively. The second efflux pump was a more selective transporter that we have called Tet38, which had 46% similarity with the plasmid-encoded TetK efflux transporter of S. aureus. tet38 was 1,353 bp and encoded a predicted 49-kDa protein. Overexpression of tet38 produced resistance to tetracycline but not to minocycline and other drugs. norB and tet38 transcription was negatively regulated by MgrA. Limited binding of MgrA to the promoter regions of norB and tet38 was demonstrated by gel shift assays, suggesting that MgrA was an indirect regulator of norB and tet38 expression. The mgrA norB double mutant was reproducibly twofold more susceptible to the tested quinolones than the mgrA mutant. The mgrA tet38 double mutant became more susceptible to tetracycline than the wild-type parent strain. These data demonstrate that overexpression of NorB and Tet38 contribute, respectively, to the hydrophobic quinolone resistance and the tetracycline resistance of the mgrA mutant and that MgrA regulates expression of norB and tet38 in addition to its role in regulation of norA expression.
在对mgrA突变体的耐药机制进行分析时,我们鉴定出两个编码此前未描述过的转运蛋白的基因,即NorB和Tet38。norB基因长度为1392 bp,编码一个预测分子量为49 kDa的蛋白质。当NorB过表达时,会导致对亲水性喹诺酮类药物、溴化乙锭、西曲溴铵以及司帕沙星、莫西沙星和四环素的耐药性增加,这是mgrA突变体的耐药表型。NorA与NorB有30%的相似性,NorB与枯草芽孢杆菌的Bmr和Blt转运蛋白分别有30%和41%的相似性。第二个外排泵是一种选择性更高的转运蛋白,我们将其命名为Tet38,它与金黄色葡萄球菌质粒编码的TetK外排转运蛋白有46%的相似性。tet38基因长度为1353 bp,编码一个预测分子量为49 kDa的蛋白质。tet38过表达产生对四环素的耐药性,但对米诺环素和其他药物无耐药性。norB和tet38的转录受到MgrA的负调控。凝胶迁移试验证明MgrA与norB和tet38的启动子区域结合有限,这表明MgrA是norB和tet38表达的间接调节因子。mgrA norB双突变体对所测试喹诺酮类药物的敏感性比mgrA突变体可重复性地高两倍。mgrA tet38双突变体对四环素的敏感性比野生型亲本菌株更高。这些数据表明,NorB和Tet38的过表达分别导致了mgrA突变体对疏水性喹诺酮类药物的耐药性和对四环素的耐药性,并且MgrA除了在调节norA表达中发挥作用外,还调节norB和tet38的表达。